Clinical
RSSArticles
-
Providers Can Reduce Vaccine Hesitancy Among Staff
As the COVID-19 vaccine was rolled out in the United States, many healthcare workers refused vaccination. Reproductive healthcare centers will need to obtain staff buy-in as they begin a vaccination program.
-
How Family Planning Providers Can Handle Challenges of COVID-19 Vaccine Rollout
The coronavirus vaccine rollout faces challenges from logistical supply issues and vaccine hesitancy among healthcare staff and the general public. From a reproductive health provider perspective, the big question is how to handle the rollout and overcome challenges on both the supply and demand sides.
-
Vitamins C and E Antioxidants Linked to Lower Parkinson’s Risk
These brain-boosting nutrients are packed into certain fruits and vegetables.
-
Statins as a Protector Against Chemotherapy
Women with early stage breast cancer shield their hearts with cholesterol-lowering drug.
-
Pregnant Women with High Blood Pressure Might Experience Memory Problems
These study participants struggled with thinking and recall exercises 15 years after the pregnancy.
-
January Is Cervical Cancer
Awareness MonthPap tests, HPV vaccines remain key prevention tools.
-
AAP, PIDS Tailor Antibiotic Recommendations for Children
Policy statement underscores importance of creating stewardship programs.
-
Why Does This WCT Change Its Shape?
Imagine there was no history for the ECG shown in the figure. How would one interpret this tracing?
-
Remdesivir Injection and Baricitinib Tablets
Baricitinib/remdesivir should be used to treat suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients ≥ age 2 years who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.
-
Using Sacubitril/Valsartan to Treat Heart Failure with Preserved Ejection Fraction
An analysis of renal outcomes in the PARAGON-HF trial revealed sacubitril/valsartan slows progression of kidney disease in patients with heart failure with preserved ejection fraction compared to valsartan alone.